10/07/2025
7:00 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2025
7:00 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2025
7:00 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2025
7:15 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2025
4:15 PM | Kairos Pharma (Filer)
| Form 424B3 | |
08/14/2025
8:12 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kairos Pharma (Subject)
| Form SCHEDULE 13G/A | |
08/12/2025
2:34 PM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/28/2025
11:43 AM | Kairos Pharma (Filer)
| Form 10-K/A | |
07/15/2025
8:11 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
7:20 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
2:38 PM | Kairos Pharma (Filer)
| Form DEFR14A | |
Get the Latest News and Ratings for KAPA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
2:19 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kairos Pharma (Subject)
| Form SCHEDULE 13G | |
05/14/2025
5:34 AM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
11:20 AM | Kairos Pharma (Filer)
| Form PRER14A | |
04/28/2025
4:28 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
4:13 PM | Kairos Pharma (Filer)
| Form 424B3 | |
04/24/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
04/24/2025
7:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
6:09 PM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/15/2025
4:30 PM | Kairos Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/07/2025
7:30 AM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
6:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
6:05 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
5:51 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:52 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
3:45 PM | Kairos Pharma (Filer)
| Form DEF 14C | |
02/06/2025
8:00 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
02/05/2025
5:15 AM | Kairos Pharma (Filer)
| Form 424B3 | |
01/29/2025
6:22 AM | Kairos Pharma (Filer)
| Form PRE 14C | |
01/29/2025
5:39 AM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/17/2025
4:20 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
8:41 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
7:30 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:03 AM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
8:53 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:48 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
1:19 PM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:30 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
